Celldex touts success of early-stage therapeutic cancer vaccine study; Cyprotex teams with Pfizer on predictive toxicology;

 @FierceBiotech: Alzheimer's investigators see fresh sign of solanezumab success in $LLY study. More | Follow @FierceBiotech

 @JohnCFierce: Biotech companies out there. You have any bad news to report? Do it now. Take advantage of the perfect storm to confess your sins quietly. | Follow @JohnCFierce

 @RyanMFierce: Focusing on hoped-for launch of tivozanib, $AVEO is axing 45 jobs or 17% of workers, eliminating 30 openings. More | Follow @RyanMFierce

> Celldex Therapeutics has claimed a first among therapeutic cancer vaccine developers, saying its CDX-1401 triggered a strong immune response in solid tumors in a Phase I study. Investigators say that's the first time an "off-the-shelf" vaccine registered such a strong response. Release

> Shares of the U.K.'s Cyprotex got a boost today from the news that it will collaborate with Pfizer ($PFE) on a research deal that covers an 18-month time span split into two stages. They'll be working on predictive toxicology. Story

> Titan Pharmaceuticals has filed an NDA for Probuphine. Story

> AET BioTech and Swiss biotech BioXpress Therapeutics have struck a deal to collaborate on a biosimilar version of adalimumab. Story

Pharma News

@FiercePharma: Korean pharma stocks are riding an updraft of M&A speculation. Keunwha, Hondok way up ... anyone shopping? More | Follow @FiercePharma

> Boehringer Ingelheim bets bigger on respiratory drugs. Story

> Bayer adds vitamin maker Schiff to buyout tally with $1.2B deal. News

> Patheon nabs Mexican beachhead with $255M Banner buyout. Report

Medical Device News

 @FierceMedDev: Ariste Medical raised $1.275M in seed money to advance development of a drug-coated vascular graft. More | Follow @FierceMedDev

 @MarkHFierce: CryoLife celebrates 13% revenue jump in Q3. More | Follow @MarkHFierce

 @DamianFierce: Orthofix pays $32M to settle allegations it gave kickbacks--including parties with strippers & prostitutes--to docs. More | Follow @DamianFierce

> Report: Global neuromodulation device market ripe for double-digit growth. Item

> Medtronic looks to unseat Edwards with heart valve. Report

Pharma Manufacturing News

> Boehringer again doubling capacity at inhaler plant. Report

> Patheon will pick up four plants with Banner buyout. News

> Congressional report calls for FDA to regulate large compounders. Article

> Drugmakers close plants ahead in face of Hurricane Sandy. Item

Biotech Research News

> Wisconsin company to provide stem cells for NIH research. Story

> Roche drug, microRNA treatment conquered head and neck cancer cells. News

> Baker's yeast yields possible Lou Gehrig's disease drug target. Article

> Duke team builds viable cartilage from induced pluripotent stem cells. Report

And Finally… Exercise doesn't just make you physically fit. A new study says it can also clearly make you smarter. Release


Suggested Articles

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.

The delay will enable Anixa to perform additional genetic engineering intended to boost the efficacy of the treatment in ovarian cancer.

The new parliamentary arithmetic gives Boris Johnson the numbers to pass the withdrawal agreement and take the U.K. out of the EU.